Rigel Pharmaceuticals | RIGL - Ebit





Ebit Alterar Data
Agenus USD 14.4M 19.26M 2025-12
Amgen USD 3.83B 130M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -141.26M 182.07M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Celldex Therapeutics USD -84.44M 2.72M 2026-03
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Intrexon USD -26.3M 2.91M 2024-06
Ionis Pharmaceuticals USD -118M 97M 2026-03
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
Ligand Pharmaceuticals USD 60.33M 1.76M 2026-03
MacroGenics USD -12.1M 32.26M 2025-12
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Pfizer USD 4.99B 340M 2026-03
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Veracyte USD 19.08M 5.55M 2026-03